25 XP   0   0   10

Bio Path Holdings Inc
Buy, Hold or Sell?

Let's analyse Bio Path Holdings Inc together

PenkeI guess you are interested in Bio Path Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bio Path Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bio Path Holdings Inc

I send you an email if I find something interesting about Bio Path Holdings Inc.

Quick analysis of Bio Path Holdings Inc (30 sec.)










What can you expect buying and holding a share of Bio Path Holdings Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.65
Expected worth in 1 year
$-0.65
How sure are you?
22.5%

+ What do you gain per year?

Total Gains per Share
$-1.30
Return On Investment
-32.1%

For what price can you sell your share?

Current Price per Share
$4.04
Expected price per share
$0 - $7.262
How sure are you?
50%

1. Valuation of Bio Path Holdings Inc (5 min.)




Live pricePrice per Share (EOD)

$4.04

Intrinsic Value Per Share

$-138.90 - $-54.45

Total Value Per Share

$-138.25 - $-53.81

2. Growth of Bio Path Holdings Inc (5 min.)




Is Bio Path Holdings Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$441k$18m-$13.7m-321.9%

How much money is Bio Path Holdings Inc making?

Current yearPrevious yearGrowGrow %
Making money-$4m-$3.4m-$556k-13.8%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Bio Path Holdings Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#868 / 1031

Most Revenue
#897 / 1031

Most Profit
#422 / 1031

Most Efficient
#342 / 1031

What can you expect buying and holding a share of Bio Path Holdings Inc? (5 min.)

Welcome investor! Bio Path Holdings Inc's management wants to use your money to grow the business. In return you get a share of Bio Path Holdings Inc.

What can you expect buying and holding a share of Bio Path Holdings Inc?

First you should know what it really means to hold a share of Bio Path Holdings Inc. And how you can make/lose money.

Speculation

The Price per Share of Bio Path Holdings Inc is $4.04. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bio Path Holdings Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bio Path Holdings Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.65. Based on the TTM, the Book Value Change Per Share is $-0.32 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.46 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bio Path Holdings Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-4.97-123.0%-1.62-40.1%-0.48-11.9%-0.82-20.2%-1.64-40.6%
Usd Book Value Change Per Share0.409.9%-0.32-8.0%-0.46-11.4%-0.06-1.4%-0.16-4.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.409.9%-0.32-8.0%-0.46-11.4%-0.06-1.4%-0.16-4.0%
Usd Price Per Share0.46-1.00-3.10-5.38-3.42-
Price to Earnings Ratio-0.02--0.42--1.67--2.29--1.24-
Price-to-Total Gains Ratio1.16--1.26--6.83--5.40--3.13-
Price to Book Ratio0.71-1.55-1.21-1.34-0.72-
Price-to-Total Gains Ratio1.16--1.26--6.83--5.40--3.13-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.04
Number of shares247
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.32-0.06
Usd Total Gains Per Share-0.32-0.06
Gains per Quarter (247 shares)-80.17-14.14
Gains per Year (247 shares)-320.70-56.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-321-3310-57-67
20-641-6520-113-124
30-962-9730-170-181
40-1283-12940-226-238
50-1603-16150-283-295
60-1924-19360-339-352
70-2245-22570-396-409
80-2566-25780-452-466
90-2886-28990-509-523
100-3207-32200-565-580

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%2.076.00.02.6%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%9.030.01.022.5%19.051.08.024.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.078.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%9.030.01.022.5%19.051.08.024.4%

Fundamentals of Bio Path Holdings Inc

About Bio Path Holdings Inc

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 (BP1002) for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 (BP1003) for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and BP1001-A for the treatment of solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.

Fundamental data was last updated by Penke on 2024-03-20 12:12:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Bio Path Holdings Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bio Path Holdings Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bio Path Holdings Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bio Path Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-632.8%+632.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--171.8%+171.8%
TTM--205.8%+205.8%
YOY--262.1%+262.1%
5Y--455.6%+455.6%
10Y-632.8%-589.0%-43.8%
1.1.2. Return on Assets

Shows how efficient Bio Path Holdings Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bio Path Holdings Inc to the Biotechnology industry mean.
  • -104.7% Return on Assets means that Bio Path Holdings Inc generated $-1.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bio Path Holdings Inc:

  • The MRQ is -104.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -70.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-104.7%TTM-70.2%-34.6%
TTM-70.2%YOY-18.0%-52.2%
TTM-70.2%5Y-24.8%-45.4%
5Y-24.8%10Y-23.4%-1.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-104.7%-12.5%-92.2%
TTM-70.2%-12.2%-58.0%
YOY-18.0%-11.2%-6.8%
5Y-24.8%-13.4%-11.4%
10Y-23.4%-14.7%-8.7%
1.1.3. Return on Equity

Shows how efficient Bio Path Holdings Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bio Path Holdings Inc to the Biotechnology industry mean.
  • -764.6% Return on Equity means Bio Path Holdings Inc generated $-7.65 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bio Path Holdings Inc:

  • The MRQ is -764.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -258.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-764.6%TTM-258.2%-506.4%
TTM-258.2%YOY-20.0%-238.2%
TTM-258.2%5Y-63.4%-194.9%
5Y-63.4%10Y-46.1%-17.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-764.6%-15.8%-748.8%
TTM-258.2%-15.7%-242.5%
YOY-20.0%-13.9%-6.1%
5Y-63.4%-18.3%-45.1%
10Y-46.1%-19.2%-26.9%

1.2. Operating Efficiency of Bio Path Holdings Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bio Path Holdings Inc is operating .

  • Measures how much profit Bio Path Holdings Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bio Path Holdings Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bio Path Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-1,361.0%+1,361.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.1%+299.1%
TTM--210.1%+210.1%
YOY--279.7%+279.7%
5Y--459.9%+459.9%
10Y-1,361.0%-596.9%-764.1%
1.2.2. Operating Ratio

Measures how efficient Bio Path Holdings Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bio Path Holdings Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y18.302-18.302
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.861-2.861
TTM-3.193-3.193
YOY-3.615-3.615
5Y-5.560-5.560
10Y18.3027.396+10.906

1.3. Liquidity of Bio Path Holdings Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bio Path Holdings Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.60 means the company has $1.60 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bio Path Holdings Inc:

  • The MRQ is 1.596. The company is able to pay all its short-term debts. +1
  • The TTM is 3.793. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ1.596TTM3.793-2.197
TTM3.793YOY12.034-8.241
TTM3.7935Y14.093-10.299
5Y14.09310Y15.515-1.422
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5963.986-2.390
TTM3.7934.440-0.647
YOY12.0345.552+6.482
5Y14.0936.158+7.935
10Y15.5156.492+9.023
1.3.2. Quick Ratio

Measures if Bio Path Holdings Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bio Path Holdings Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.55 means the company can pay off $0.55 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bio Path Holdings Inc:

  • The MRQ is 0.552. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 2.056. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.552TTM2.056-1.504
TTM2.056YOY9.701-7.645
TTM2.0565Y12.246-10.190
5Y12.24610Y13.917-1.671
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5523.638-3.086
TTM2.0564.168-2.112
YOY9.7015.515+4.186
5Y12.2466.012+6.234
10Y13.9176.209+7.708

1.4. Solvency of Bio Path Holdings Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bio Path Holdings Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bio Path Holdings Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.86 means that Bio Path Holdings Inc assets are financed with 86.3% credit (debt) and the remaining percentage (100% - 86.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bio Path Holdings Inc:

  • The MRQ is 0.863. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.442. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.863TTM0.442+0.421
TTM0.442YOY0.096+0.346
TTM0.4425Y0.150+0.292
5Y0.15010Y0.140+0.010
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8630.335+0.528
TTM0.4420.330+0.112
YOY0.0960.267-0.171
5Y0.1500.367-0.217
10Y0.1400.378-0.238
1.4.2. Debt to Equity Ratio

Measures if Bio Path Holdings Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bio Path Holdings Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 630.2% means that company has $6.30 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bio Path Holdings Inc:

  • The MRQ is 6.302. The company is unable to pay all its debts with equity. -1
  • The TTM is 1.951. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ6.302TTM1.951+4.351
TTM1.951YOY0.107+1.844
TTM1.9515Y0.458+1.493
5Y0.45810Y0.318+0.140
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.3020.376+5.926
TTM1.9510.398+1.553
YOY0.1070.334-0.227
5Y0.4580.429+0.029
10Y0.3180.476-0.158

2. Market Valuation of Bio Path Holdings Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bio Path Holdings Inc generates.

  • Above 15 is considered overpriced but always compare Bio Path Holdings Inc to the Biotechnology industry mean.
  • A PE ratio of -0.02 means the investor is paying $-0.02 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bio Path Holdings Inc:

  • The EOD is -0.203. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.023. Based on the earnings, the company is expensive. -2
  • The TTM is -0.419. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.203MRQ-0.023-0.180
MRQ-0.023TTM-0.419+0.396
TTM-0.419YOY-1.665+1.246
TTM-0.4195Y-2.289+1.870
5Y-2.28910Y-1.239-1.051
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.203-2.643+2.440
MRQ-0.023-2.418+2.395
TTM-0.419-2.742+2.323
YOY-1.665-4.123+2.458
5Y-2.289-6.257+3.968
10Y-1.239-6.478+5.239
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bio Path Holdings Inc:

  • The EOD is -0.378. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.043. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.553. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.378MRQ-0.043-0.335
MRQ-0.043TTM-0.553+0.510
TTM-0.553YOY-1.653+1.100
TTM-0.5535Y-2.272+1.719
5Y-2.27210Y-1.234-1.039
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.378-3.244+2.866
MRQ-0.043-2.939+2.896
TTM-0.553-3.478+2.925
YOY-1.653-5.592+3.939
5Y-2.272-8.473+6.201
10Y-1.234-8.881+7.647
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bio Path Holdings Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.71 means the investor is paying $0.71 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bio Path Holdings Inc:

  • The EOD is 6.218. Based on the equity, the company is overpriced. -1
  • The MRQ is 0.713. Based on the equity, the company is cheap. +2
  • The TTM is 1.553. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD6.218MRQ0.713+5.506
MRQ0.713TTM1.553-0.840
TTM1.553YOY1.209+0.343
TTM1.5535Y1.341+0.211
5Y1.34110Y0.724+0.617
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.2182.124+4.094
MRQ0.7132.041-1.328
TTM1.5532.118-0.565
YOY1.2092.915-1.706
5Y1.3413.682-2.341
10Y0.7244.114-3.390
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bio Path Holdings Inc.

3.1. Institutions holding Bio Path Holdings Inc

Institutions are holding 4.399% of the shares of Bio Path Holdings Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc2.1853027002911791477.5164
2023-12-31Geode Capital Management, LLC0.893801104381598916.9287
2023-12-31BlackRock Inc0.4427054709624012.8742
2023-12-31Strategic Advocates LLC0.28420.00693511900
2023-12-31UBS Group AG0.1844022788227880
2023-12-31Northern Trust Corp0.143301771100
2023-12-31HRT FINANCIAL LLC0.140.000117294-629-3.5095
2023-12-31XTX Topco Ltd0.12460.0016154003782.5163
2023-12-31State Street Corporation0.105501303300
2023-12-31Tower Research Capital LLC0.07870.00019723-9028-48.1468
2023-12-31Group One Trading, LP0.04450550000
2023-12-31Morgan Stanley - Brokerage Accounts0.0057070000
2023-12-31Bank of America Corp0.0012015200
2023-12-31Hanson Mcclain Inc0.001201501500
2023-12-31Wells Fargo & Co0.00080951113.0952
2023-12-31Global Retirement Partners, LLC.0.000606900
2023-12-31Royal Bank of Canada0.000202000
2023-12-31Advisor Group Holdings, Inc.0.000101000
2023-12-31Warberg Asset Management LLC000-24000-100
2023-12-31Millennium Management LLC000-18571-100
Total 4.63680.0087572940+111242+19.4%

3.2. Funds holding Bio Path Holdings Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Fidelity Extended Market Index0.64710.00017996400
2024-01-31Fidelity Nasdaq Composite Index0.122201510000
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr2.18540.00011350210.0074
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.08890.00011098700
2024-01-31Fidelity Series Total Market Index0.07840968300
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.07140.00018824170.193
2023-12-31NT Ext Equity Mkt Idx Fd - L0.04930.0001609000
2023-12-31Northern Trust Extended Eq Market Idx0.04930.0001609000
2024-01-31Fidelity Total Market Index0.02750339200
2024-01-31Spartan Total Market Index Pool E0.01490184500
2023-09-30BlackRock Extended Mkt Composite0.0039048300
2024-01-31Spartan Extended Market Index Pool E0.0037045400
2023-12-31BlackRock Extended Equity Market K0.00340421-1-0.237
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00290.000135510.2825
2023-12-31Northern Trust Wilshire 50000.002025000
2023-12-31NT US Market Cap Idx Fd - L0.002025000
2023-12-31SSgA U.S. Extended Market Index Class I0.0014017500
2023-12-31Extended Equity Market Fund M0.000405224
2023-12-31SSgA U.S. Total Market Index Strategy0.0004050-1-1.9608
2023-12-31BNYM Mellon SL Market Completion UC10.0004046-1-2.1277
Total 3.35490.0007158013+18+0.0%

3.3. Insider Transactions

Insiders are holding 0.251% of the shares of Bio Path Holdings Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2019-01-18Armistice Capital Master FundSELL644572.66
2015-07-13Michael J GarrisonBUY73431.22
2015-07-09Michael J GarrisonBUY87241.17
2015-07-08Michael J GarrisonBUY600001.19

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Bio Path Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.399-0.325+181%-0.459+215%-0.057+114%-0.160+140%
Book Value Per Share--0.6500.670-3%2.513-74%3.941-84%9.113-93%
Current Ratio--1.5963.793-58%12.034-87%14.093-89%15.515-90%
Debt To Asset Ratio--0.8630.442+95%0.096+801%0.150+476%0.140+517%
Debt To Equity Ratio--6.3021.951+223%0.107+5808%0.458+1277%0.318+1882%
Dividend Per Share----0%-0%-0%-0%
Eps---4.968-1.619-67%-0.481-90%-0.818-84%-1.638-67%
Free Cash Flow Per Share---2.672-0.955-64%-0.525-80%-0.691-74%-1.523-43%
Free Cash Flow To Equity Per Share---1.915-0.724-62%-0.465-76%0.682-381%2.122-190%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---54.455--------
Intrinsic Value_10Y_min---138.901--------
Intrinsic Value_1Y_max---2.905--------
Intrinsic Value_1Y_min---7.468--------
Intrinsic Value_3Y_max---10.673--------
Intrinsic Value_3Y_min---28.158--------
Intrinsic Value_5Y_max---20.786--------
Intrinsic Value_5Y_min---54.959--------
Market Cap2742331.800+89%314282.0857316773.021-96%22257690.000-99%22588059.604-99%11787391.584-97%
Net Profit Margin----0%-0%-0%-6.3280%
Operating Margin----0%-0%-0%-13.6100%
Operating Ratio----0%-0%-0%18.302-100%
Pb Ratio6.218+89%0.7131.553-54%1.209-41%1.341-47%0.724-2%
Pe Ratio-0.203-773%-0.023-0.419+1699%-1.665+7046%-2.289+9725%-1.239+5215%
Price Per Share4.040+89%0.4631.001-54%3.103-85%5.378-91%3.416-86%
Price To Free Cash Flow Ratio-0.378-773%-0.043-0.553+1177%-1.653+3716%-2.272+5146%-1.234+2748%
Price To Total Gains Ratio10.138+89%1.162-1.255+208%-6.834+688%-5.404+565%-3.127+369%
Quick Ratio--0.5522.056-73%9.701-94%12.246-95%13.917-96%
Return On Assets---1.047-0.702-33%-0.180-83%-0.248-76%-0.234-78%
Return On Equity---7.646-2.582-66%-0.200-97%-0.634-92%-0.461-94%
Total Gains Per Share--0.399-0.325+181%-0.459+215%-0.057+114%-0.160+140%
Usd Book Value--441000.0004279000.000-90%18051500.000-98%17130850.000-97%13413728.200-97%
Usd Book Value Change Per Share--0.399-0.325+181%-0.459+215%-0.057+114%-0.160+140%
Usd Book Value Per Share--0.6500.670-3%2.513-74%3.941-84%9.113-93%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---4.968-1.619-67%-0.481-90%-0.818-84%-1.638-67%
Usd Free Cash Flow---1814000.000-2883750.000+59%-3775750.000+108%-2794950.000+54%-2196601.850+21%
Usd Free Cash Flow Per Share---2.672-0.955-64%-0.525-80%-0.691-74%-1.523-43%
Usd Free Cash Flow To Equity Per Share---1.915-0.724-62%-0.465-76%0.682-381%2.122-190%
Usd Market Cap2742331.800+89%314282.0857316773.021-96%22257690.000-99%22588059.604-99%11787391.584-97%
Usd Price Per Share4.040+89%0.4631.001-54%3.103-85%5.378-91%3.416-86%
Usd Profit---3372000.000-4014750.000+19%-3458750.000+3%-2990750.000-11%-2310218.500-31%
Usd Revenue----0%-0%-0%2500.000-100%
Usd Total Gains Per Share--0.399-0.325+181%-0.459+215%-0.057+114%-0.160+140%
 EOD+6 -2MRQTTM+9 -20YOY+9 -205Y+8 -2110Y+9 -22

4.2. Fundamental Score

Let's check the fundamental score of Bio Path Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.203
Price to Book Ratio (EOD)Between0-16.218
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.552
Current Ratio (MRQ)Greater than11.596
Debt to Asset Ratio (MRQ)Less than10.863
Debt to Equity Ratio (MRQ)Less than16.302
Return on Equity (MRQ)Greater than0.15-7.646
Return on Assets (MRQ)Greater than0.05-1.047
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of Bio Path Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.768
Ma 20Greater thanMa 505.181
Ma 50Greater thanMa 1007.066
Ma 100Greater thanMa 2008.725
OpenGreater thanClose4.140
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Total Other Income Expense Net 20-119-1186472-415-343



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets3,220
Total Liabilities2,779
Total Stockholder Equity441
 As reported
Total Liabilities 2,779
Total Stockholder Equity+ 441
Total Assets = 3,220

Assets

Total Assets3,220
Total Current Assets3,042
Long-term Assets178
Total Current Assets
Cash And Cash Equivalents 1,052
Other Current Assets 1,990
Total Current Assets  (as reported)3,042
Total Current Assets  (calculated)3,042
+/-0
Long-term Assets
Property Plant Equipment 178
Long-term Assets  (as reported)178
Long-term Assets  (calculated)178
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,906
Long-term Liabilities873
Total Stockholder Equity441
Total Current Liabilities
Short-term Debt 103
Accounts payable 457
Other Current Liabilities 1,346
Total Current Liabilities  (as reported)1,906
Total Current Liabilities  (calculated)1,906
+/-0
Long-term Liabilities
Capital Lease Obligations 113
Long-term Liabilities  (as reported)873
Long-term Liabilities  (calculated)113
+/- 760
Total Stockholder Equity
Common Stock1
Retained Earnings -107,607
Other Stockholders Equity 108,047
Total Stockholder Equity (as reported)441
Total Stockholder Equity (calculated)441
+/-0
Other
Capital Stock1
Cash and Short Term Investments 1,052
Common Stock Shares Outstanding 618
Liabilities and Stockholders Equity 3,220
Net Debt -939
Net Invested Capital 441
Net Working Capital 1,136
Property Plant and Equipment Gross 1,222
Short Long Term Debt Total 113



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-30
> Total Assets 
0
0
0
142
142
143
145
145
131
117
70
49
117
59
5,018
4,767
4,540
4,387
4,387
3,602
3,354
3,682
3,604
3,741
3,208
3,109
3,262
3,664
3,404
3,231
2,708
2,165
2,070
2,344
2,344
3,745
5,751
5,079
18,598
17,365
16,285
15,478
14,249
13,293
11,673
10,755
8,946
7,140
13,442
12,196
10,111
9,431
7,316
8,858
8,858
5,742
3,945
2,335
21,319
19,319
17,595
22,660
19,826
17,520
14,873
16,475
33,099
31,127
30,680
26,568
24,078
21,009
18,539
15,971
11,102
6,524
5,021
3,220
3,2205,0216,52411,10215,97118,53921,00924,07826,56830,68031,12733,09916,47514,87317,52019,82622,66017,59519,31921,3192,3353,9455,7428,8588,8587,3169,43110,11112,19613,4427,1408,94610,75511,67313,29314,24915,47816,28517,36518,5985,0795,7513,7452,3442,3442,0702,1652,7083,2313,4043,6643,2623,1093,2083,7413,6043,6823,3543,6024,3874,3874,5404,7675,018591174970117131145145143142142000
   > Total Current Assets 
0
0
0
44
44
35
37
37
35
21
66
45
22
55
2,534
2,325
2,116
1,883
1,883
1,163
951
1,250
1,195
1,313
747
644
817
1,267
1,035
1,154
654
504
458
772
772
2,253
4,299
3,667
17,226
16,034
14,927
14,114
12,935
12,029
10,460
9,593
7,834
6,079
12,407
10,653
8,350
7,785
5,787
7,435
7,435
4,514
2,824
1,929
20,866
18,605
16,886
21,990
19,193
16,924
14,315
15,956
32,618
30,639
30,233
26,140
23,610
20,563
18,137
15,615
10,791
6,259
4,802
3,042
3,0424,8026,25910,79115,61518,13720,56323,61026,14030,23330,63932,61815,95614,31516,92419,19321,99016,88618,60520,8661,9292,8244,5147,4357,4355,7877,7858,35010,65312,4076,0797,8349,59310,46012,02912,93514,11414,92716,03417,2263,6674,2992,2537727724585046541,1541,0351,2678176447471,3131,1951,2509511,1631,8831,8832,1162,3252,5345522456621353737354444000
       Cash And Cash Equivalents 
0
0
0
5
5
12
15
15
10
5
54
33
10
17
2,506
2,253
1,775
1,507
1,507
516
266
567
455
602
106
239
766
1,222
983
952
577
162
333
534
534
1,927
4,101
3,552
16,820
15,721
14,637
13,859
12,454
11,080
9,855
8,855
6,473
4,224
11,299
9,375
7,111
6,182
4,623
5,965
5,965
2,578
2,286
1,004
19,276
17,106
15,382
20,426
17,891
14,411
12,058
13,755
30,793
28,093
26,601
23,774
21,248
17,024
13,650
10,384
6,731
3,444
2,352
1,052
1,0522,3523,4446,73110,38413,65017,02421,24823,77426,60128,09330,79313,75512,05814,41117,89120,42615,38217,10619,2761,0042,2862,5785,9655,9654,6236,1827,1119,37511,2994,2246,4738,8559,85511,08012,45413,85914,63715,72116,8203,5524,1011,9275345343331625779529831,2227662391066024555672665161,5071,5071,7752,2532,5061710335451015151255000
       Net Receivables 
0
0
0
11
11
0
0
12
12
12
12
0
12
12
0
0
0
0
0
0
0
0
0
0
0
244
244
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-2
-4
-2
-1
0
0
00-1-2-4-2000000000000000000000000000000000000000000000244244000000000001212012121212001111000
       Other Current Assets 
0
0
0
1
1
1
0
0
1
0
0
0
1
38
29
72
341
83
83
56
77
74
132
103
110
73
51
45
52
48
56
46
45
43
43
46
50
64
157
172
194
100
123
254
201
179
750
1,276
912
902
862
1,011
511
1,470
353
604
281
593
1,163
845
1,504
788
538
2,513
1,277
2,201
850
1,010
1,519
2,366
1,410
-8
4,487
5,231
4,060
2,815
2,450
1,990
1,9902,4502,8154,0605,2314,487-81,4102,3661,5191,0108502,2011,2772,5135387881,5048451,1635932816043531,4705111,0118629029121,2767501792012541231001941721576450464343454656485245517311010313274775683833417229381000100111000
   > Long-term Assets 
0
0
0
98
98
108
108
108
96
96
0
0
95
4
2,484
2,441
2,423
2,505
2,505
2,439
2,403
2,432
2,409
2,428
2,461
2,464
2,445
2,397
2,369
2,077
2,054
1,661
1,612
3,144
1,572
1,492
1,452
1,412
1,371
1,331
1,357
1,364
1,314
1,263
1,213
1,162
1,112
1,061
1,035
1,543
1,761
1,646
1,529
1,423
1,423
1,228
1,121
406
453
714
709
670
633
596
558
519
481
488
447
428
468
446
402
356
311
265
219
178
1782192653113564024464684284474884815195585966336707097144534061,1211,2281,4231,4231,5291,6461,7611,5431,0351,0611,1121,1621,2131,2631,3141,3641,3571,3311,3711,4121,4521,4921,5723,1441,6121,6612,0542,0772,3692,3972,4452,4642,4612,4282,4092,4322,4032,4392,5052,5052,4232,4412,4844950096961081081089898000
       Property Plant Equipment 
0
0
0
94
94
93
93
93
92
92
0
0
91
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
66
113
103
93
82
72
62
51
66
614
872
797
720
654
654
539
473
406
453
714
709
670
633
596
558
519
481
488
447
428
468
446
402
356
311
265
219
178
17821926531135640244646842844748848151955859663367070971445340647353965465472079787261466516272829310311366000000000000000000000000000910092929393939494000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,484
2,441
2,423
2,505
2,505
2,439
2,403
0
2,409
2,428
2,461
2,464
2,445
2,397
2,369
2,077
2,054
1,661
1,612
1,572
1,572
1,492
1,452
1,412
1,371
1,331
1,291
1,251
1,211
1,171
1,130
1,090
1,050
1,010
969
929
889
849
809
769
769
689
648
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000006486897697698098498899299691,0101,0501,0901,1301,1711,2111,2511,2911,3311,3711,4121,4521,4921,5721,5721,6121,6612,0542,0772,3692,3972,4452,4642,4612,4282,40902,4032,4392,5052,5052,4232,4412,48400000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,054
1,661
1,612
1,572
1,532
1,492
1,452
1,412
1,372
1,331
1,292
1,251
1,211
1,171
1,131
1,090
1,050
1,010
969
929
889
849
809
769
729
689
648
0
0
0
0
0
0
0
0
519
0
0
0
0
0
0
0
0
0
0
0
0
000000000000519000000006486897297698098498899299691,0101,0501,0901,1311,1711,2111,2511,2921,3311,3721,4121,4521,4921,5321,5721,6121,6612,054000000000000000000000000000000
> Total Liabilities 
0
0
0
319
319
140
162
162
232
251
193
190
284
328
15
7
2
327
327
230
247
265
336
413
72
247
188
221
205
316
247
243
269
329
329
268
174
295
420
334
283
562
616
692
481
937
900
813
4,065
3,956
2,019
576
767
791
791
1,005
957
1,117
1,176
1,406
1,571
1,574
1,894
1,509
1,687
1,405
1,726
1,373
1,334
1,111
1,763
1,489
2,342
1,797
1,995
1,481
2,496
2,779
2,7792,4961,4811,9951,7972,3421,4891,7631,1111,3341,3731,7261,4051,6871,5091,8941,5741,5711,4061,1761,1179571,0057917917675762,0193,9564,065813900937481692616562283334420295174268329329269243247316205221188247724133362652472303273272715328284190193251232162162140319319000
   > Total Current Liabilities 
0
0
0
319
319
60
82
82
153
173
193
190
206
328
15
7
2
327
327
230
247
265
336
413
72
247
188
221
205
316
247
243
269
329
329
268
174
295
420
334
283
562
616
692
481
937
900
813
866
1,050
709
576
767
791
791
1,005
957
1,117
1,117
1,033
1,219
1,244
1,587
1,225
1,427
1,169
1,515
1,183
1,162
958
1,568
1,321
2,201
1,684
1,910
1,426
1,357
1,906
1,9061,3571,4261,9101,6842,2011,3211,5689581,1621,1831,5151,1691,4271,2251,5871,2441,2191,0331,1171,1179571,0057917917675767091,050866813900937481692616562283334420295174268329329269243247316205221188247724133362652472303273272715328206190193173153828260319319000
       Short-term Debt 
0
0
0
245
245
32
54
54
55
64
82
61
90
48
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54
34
79
85
87
89
92
94
96
94
88
82
101
102
105
108
110
113
116
103
10311611311010810510210182889496949289878579345400000000000000000000000000000000000000000000489061826455545432245245000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000540000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
33
33
9
21
0
34
47
0
0
52
31
1
1
0
186
186
2
5
6
0
124
9
88
26
24
43
190
58
54
65
329
66
176
44
76
238
79
89
41
77
385
127
55
201
123
118
69
89
96
121
791
52
137
451
813
607
444
522
486
818
726
614
100
394
507
417
106
409
611
1,046
667
827
638
277
457
4572776388276671,0466114091064175073941006147268184865224446078134511375279112196896911812320155127385774189792387644176663296554581904324268891240652186186011315200473402193333000
       Other Current Liabilities 
0
0
0
42
1
1
1
0
1
62
0
0
0
249
14
6
2
141
141
228
242
258
336
289
63
158
162
197
162
127
188
189
203
264
264
92
130
219
182
255
195
521
540
307
354
883
699
690
748
969
608
468
634
739
739
868
506
304
54
555
618
673
682
410
721
975
1,025
582
657
770
1,058
608
1,050
909
973
675
964
1,346
1,3469646759739091,0506081,0587706575821,0259757214106826736185555430450686873973963446860896974869069988335430754052119525518221913092264264203189188127162197162158632893362582422281411412614249000621011142000
   > Long-term Liabilities 
0
0
0
0
277
80
80
80
79
78
0
0
77
79
1
1
0
0
186
2
5
6
0
124
9
88
26
24
43
190
58
54
65
0
66
176
44
76
238
79
89
41
77
385
127
55
201
123
3,199
2,906
1,310
108
133
0
52
137
451
813
59
373
352
330
307
284
260
236
211
190
172
153
195
168
141
113
85
55
1,139
873
8731,1395585113141168195153172190211236260284307330352373598134511375201331081,3102,9063,199123201551273857741897923876441766606554581904324268891240652186001179770078798080802770000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,199
2,906
1,310
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000001,3102,9063,199000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,199
2,906
1,310
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000001,3102,9063,199000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
-177
-177
3
-17
0
-100
-134
0
0
-166
-269
5,003
4,759
4,538
4,060
4,060
3,372
3,107
3,417
3,269
3,328
3,136
2,862
3,074
3,443
3,199
2,915
2,462
1,922
1,801
2,015
2,015
3,477
5,577
4,784
18,178
17,032
16,001
14,916
13,633
12,600
11,191
9,818
8,046
6,327
9,377
8,240
8,092
8,855
6,549
8,067
8,067
4,737
2,988
1,218
20,143
17,913
16,024
21,086
17,932
16,011
13,186
15,070
31,373
29,754
29,346
25,457
22,315
19,520
16,197
14,174
9,107
5,043
2,525
441
4412,5255,0439,10714,17416,19719,52022,31525,45729,34629,75431,37315,07013,18616,01117,93221,08616,02417,91320,1431,2182,9884,7378,0678,0676,5498,8558,0928,2409,3776,3278,0469,81811,19112,60013,63314,91616,00117,03218,1784,7845,5773,4772,0152,0151,8011,9222,4622,9153,1993,4433,0742,8623,1363,3283,2693,4173,1073,3724,0604,0604,5384,7595,003-269-16600-134-1000-173-177-177000
   Common Stock
0
0
0
0
0
1,774
1,880
0
415
0
0
0
2,736
0
42
42
42
0
42
43
43
43
47
49
49
49
49
56
56
58
58
59
59
62
62
75
75
84
89
89
89
90
90
90
90
90
90
90
96
96
96
100
100
11
11
11
13
1
3
3
3
4
4
4
4
5
7
7
7
7
7
7
7
8
8
8
11
1
111888777777754444333113111111100100969696909090909090908989898475756262595958585656494949494743434342042424202,73600041501,8801,77400000
   Retained Earnings Total Equity0000000000-71,476-69,668-67,221-64,671-61,703-59,663-56,339-53,950-51,708-49,252-47,740-45,831-42,750-41,073-39,157-36,990-34,516-32,531-32,134-30,763-29,193-27,251-25,384-23,925-22,417-21,292-19,917-18,319-17,171-15,902-15,397-14,608-13,215-12,787-12,131-11,699-10,859-10,071-9,549-8,745-8,241000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-14
-14
-1,793
-16
-16
-16
-17
-2
0
-18
110
0
0
0
0
0
0
-4,671
0
-5,595
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-10
-21
-31
-41
-51
-61
-72
-82
-94
-127
-202
-279
-330
-330
-462
-528
-592
-658
-691
-708
-726
-744
-762
-780
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000-780-762-744-726-708-691-658-592-528-462-330-330-279-202-127-94-82-72-61-51-41-31-21-10000000000000000000-5,5950-4,671000000110-180-2-17-16-16-16-1,793-14-14000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,628
11,888
12,405
12,474
12,722
13,442
14,084
14,405
16,616
20,109
20,097
33,991
34,113
34,231
34,743
34,835
34,928
35,027
35,112
35,207
35,430
40,044
40,278
40,527
43,271
43,439
47,213
47,337
47,476
48,806
48,957
69,392
69,618
69,971
77,421
77,591
77,710
77,853
82,286
101,034
101,223
0
0
0
0
0
0
0
0
0
0
0000000000101,223101,03482,28677,85377,71077,59177,42169,97169,61869,39248,95748,80647,47647,33747,21343,43943,27140,52740,27840,04435,43035,20735,11235,02734,92834,83534,74334,23134,11333,99120,09720,10916,61614,40514,08413,44212,72212,47412,40511,88811,628000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
191
177
416
-1,460
0
420
437
0
0
-2,316
433
5,469
5,721
5,739
7,194
7,152
7,593
7,736
8,478
8,817
9,301
9,610
9,998
10,802
11,628
11,888
12,405
12,474
12,722
13,442
0
14,084
16,616
20,109
20,097
33,991
34,113
34,231
34,743
34,835
34,928
35,027
35,112
35,207
35,430
40,044
40,278
40,527
43,271
43,439
0
47,213
47,476
48,806
48,957
69,392
69,618
69,971
77,421
77,591
77,710
77,853
82,286
101,034
101,223
102,884
103,111
103,328
103,541
103,753
105,695
105,901
106,071
106,749
108,047
108,047106,749106,071105,901105,695103,753103,541103,328103,111102,884101,223101,03482,28677,85377,71077,59177,42169,97169,61869,39248,95748,80647,47647,213043,43943,27140,52740,27840,04435,43035,20735,11235,02734,92834,83534,74334,23134,11333,99120,09720,10916,61614,084013,44212,72212,47412,40511,88811,62810,8029,9989,6109,3018,8178,4787,7367,5937,1527,1945,7395,7215,469433-2,316004374200-1,460416177191000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-178
Gross Profit-178-178
 
Operating Income (+$)
Gross Profit-178
Operating Expense-15,665
Operating Income-15,843-15,843
 
Operating Expense (+$)
Research Development11,608
Selling General Administrative4,235
Selling And Marketing Expenses178
Operating Expense15,66516,021
 
Net Interest Income (+$)
Interest Income52
Interest Expense-0
Other Finance Cost-0
Net Interest Income52
 
Pretax Income (+$)
Operating Income-15,843
Net Interest Income52
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-16,078-15,608
EBIT - interestExpense = -15,843
-16,078
-16,078
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-15,843-16,078
Earnings Before Interest and Taxes (EBITDA)-15,665
 
After tax Income (+$)
Income Before Tax-16,078
Tax Provision-0
Net Income From Continuing Ops-16,672-16,078
Net Income-16,078
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses15,843
Total Other Income/Expenses Net-235-52
 

Technical Analysis of Bio Path Holdings Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bio Path Holdings Inc. The general trend of Bio Path Holdings Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bio Path Holdings Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bio Path Holdings Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.6 < 7.002 < 7.262.

The bearish price targets are: .

Tweet this
Bio Path Holdings Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bio Path Holdings Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bio Path Holdings Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bio Path Holdings Inc. The current macd is -0.92331126.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bio Path Holdings Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bio Path Holdings Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bio Path Holdings Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Bio Path Holdings Inc Daily Moving Average Convergence/Divergence (MACD) ChartBio Path Holdings Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bio Path Holdings Inc. The current adx is 18.27.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bio Path Holdings Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Bio Path Holdings Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bio Path Holdings Inc. The current sar is 6.13662929.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bio Path Holdings Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bio Path Holdings Inc. The current rsi is 29.77. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
Bio Path Holdings Inc Daily Relative Strength Index (RSI) ChartBio Path Holdings Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bio Path Holdings Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bio Path Holdings Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Bio Path Holdings Inc Daily Stochastic Oscillator ChartBio Path Holdings Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bio Path Holdings Inc. The current cci is -107.50458356.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Bio Path Holdings Inc Daily Commodity Channel Index (CCI) ChartBio Path Holdings Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bio Path Holdings Inc. The current cmo is -42.13395454.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bio Path Holdings Inc Daily Chande Momentum Oscillator (CMO) ChartBio Path Holdings Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bio Path Holdings Inc. The current willr is -86.71679198.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Bio Path Holdings Inc Daily Williams %R ChartBio Path Holdings Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bio Path Holdings Inc.

Bio Path Holdings Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bio Path Holdings Inc. The current atr is 0.84281181.

Bio Path Holdings Inc Daily Average True Range (ATR) ChartBio Path Holdings Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bio Path Holdings Inc. The current obv is 6,488,073.

Bio Path Holdings Inc Daily On-Balance Volume (OBV) ChartBio Path Holdings Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bio Path Holdings Inc. The current mfi is 58.74.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Bio Path Holdings Inc Daily Money Flow Index (MFI) ChartBio Path Holdings Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bio Path Holdings Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Bio Path Holdings Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bio Path Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.768
Ma 20Greater thanMa 505.181
Ma 50Greater thanMa 1007.066
Ma 100Greater thanMa 2008.725
OpenGreater thanClose4.140
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bio Path Holdings Inc with someone you think should read this too:
  • Are you bullish or bearish on Bio Path Holdings Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bio Path Holdings Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bio Path Holdings Inc

I send you an email if I find something interesting about Bio Path Holdings Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Bio Path Holdings Inc.

Receive notifications about Bio Path Holdings Inc in your mailbox!